Works by Kivitz, Alan J.

Results: 58

Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies.

Published in:

Rheumatology & Therapy, 2024, v. 11, n. 3, p. 675, doi. 10.1007/s40744-024-00666-1

By:

Kivitz, Alan J.;
Kremer, Joel M.;
Legerton III, Clarence W.;
Pricop, Luminita;
Singhal, Atul

Publication type:

Article

Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.

Published in:

2023

By:

Combe, Bernard G.;
Tanaka, Yoshiya;
Buch, Maya H.;
Nash, Peter;
Burmester, Gerd R.;
Kivitz, Alan J.;
Bartok, Beatrix;
Pechonkina, Alena;
Xia, Katrina;
Emoto, Kahaku;
Kano, Shungo;
Hendrikx, Thijs K.;
Landewé, Robert B. M.;
Aletaha, Daniel

Publication type:

Correction Notice

Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 1, p. 53, doi. 10.1007/s40744-022-00498-x

By:

Combe, Bernard G.;
Tanaka, Yoshiya;
Buch, Maya H.;
Nash, Peter;
Burmester, Gerd R.;
Kivitz, Alan J.;
Bartok, Beatrix;
Pechonkina, Alena;
Xia, Katrina;
Emoto, Kahaku;
Kano, Shungo;
Hendrikx, Thijs K.;
Landewé, Robert B. M.;
Aletaha, Daniel

Publication type:

Article

Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial.

Published in:

Rheumatology & Therapy, 2022, v. 9, n. 5, p. 1361, doi. 10.1007/s40744-022-00474-5

By:

Mease, Philip J.;
Kellner, Herbert;
Morita, Akimichi;
Kivitz, Alan J.;
Aslanyan, Stella;
Padula, Steven J.;
Topp, Andrew S.;
Eldred, Ann;
Behrens, Frank;
Papp, Kim A.

Publication type:

Article

A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 4, p. 1775, doi. 10.1007/s40744-021-00380-2

By:

van der Horst-Bruinsma, Irene;
Miceli-Richard, Corinne;
Braun, Juergen;
Marzo-Ortega, Helena;
Pavelka, Karel;
Kivitz, Alan J.;
Deodhar, Atul;
Bao, Weibin;
Porter, Brian;
Pournara, Effie

Publication type:

Article

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 4, p. 775, doi. 10.1007/s40744-020-00226-3

By:

Bergman, Martin J.;
Kivitz, Alan J.;
Pappas, Dimitrios A.;
Kremer, Joel M.;
Zhang, Lixia;
Jeter, Anna;
Withers, Johanna B.

Publication type:

Article

Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 3, p. 553, doi. 10.1007/s40744-020-00209-4

By:

Nash, Peter;
Coates, Laura C.;
Kivitz, Alan J.;
Mease, Philip J.;
Gladman, Dafna D.;
Covarrubias-Cobos, José A.;
FitzGerald, Oliver;
Fleishaker, Dona;
Wang, Cunshan;
Wu, Joseph;
Hsu, Ming-Ann;
Menon, Sujatha;
Fallon, Lara;
Romero, Ana Belén;
Kanik, Keith S.

Publication type:

Article

Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 1, p. 101, doi. 10.1007/s40744-019-00182-7

By:

Schafer, Peter H.;
Kivitz, Alan J.;
Ma, Jianglin;
Korish, Shimon;
Sutherland, Donna;
Li, Li;
Azaryan, Ada;
Kosek, Jolanta;
Adams, Mary;
Capone, Lori;
Hur, Eun Mi;
Hough, Douglas R.;
Ringheim, Garth E.

Publication type:

Article

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.

Published in:

Rheumatology & Therapy, 2019, v. 6, n. 4, p. 503, doi. 10.1007/s40744-019-00167-6

By:

Genovese, Mark C.;
Greenwald, Maria W.;
Gutierrez-Ureña, Sergio R.;
Cardiel, Mario H.;
Poiley, Jeffrey E.;
Zubrzycka-Sienkiewicz, Anna;
Codding, Christine E.;
Wang, Annie;
He, Weizhong;
Amos, Rebecca;
Vinueza, Raul;
Wang, Xuegong;
Garg, Jay P.;
Kivitz, Alan J.

Publication type:

Article

Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study.

Published in:

Rheumatology & Therapy, 2019, v. 6, n. 3, p. 393, doi. 10.1007/s40744-019-0163-5

By:

Kivitz, Alan J.;
Nash, Peter;
Tahir, Hasan;
Everding, Andrea;
Mann, Heřman;
Kaszuba, Andrzej;
Pellet, Pascale;
Widmer, Albert;
Pricop, Luminita;
Abrams, Ken

Publication type:

Article

Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study.

Published in:

Rheumatology & Therapy, 2018, v. 5, n. 2, p. 447, doi. 10.1007/s40744-018-0123-5

By:

Kivitz, Alan J.;
Wagner, Ulf;
Dokoupilova, Eva;
Supronik, Jerzy;
Martin, Ruvie;
Talloczy, Zsolt;
Richards, Hanno B.;
Porter, Brian

Publication type:

Article

Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses.

Published in:

Rheumatology & Therapy, 2018, v. 5, n. 2, p. 341, doi. 10.1007/s40744-018-0113-7

By:

Strand, Vibeke;
Kavanaugh, Arthur;
Kivitz, Alan J.;
van der Heijde, Désirée;
Kwok, Kenneth;
Akylbekova, Ermeg;
Soonasra, Arif;
Snyder, Mark;
Connell, Carol;
Bananis, Eustratios;
Smolen, Josef S.

Publication type:

Article

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.

Published in:

2016

By:

Bickham, Kara;
Kivitz, Alan J.;
Mehta, Anish;
Frontera, Nancy;
Shah, Sandhya;
Stryszak, Paul;
Popmihajlov, Zoran;
Peloso, Paul M.

Publication type:

journal article

Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.

Published in:

Modern Rheumatology, 2023, v. 33, n. 4, p. 668, doi. 10.1093/mr/roac084

By:

Tanaka, Yoshiya;
Matsubara, Tsukasa;
Atsumi, Tatsuya;
Amano, Koichi;
Ishiguro, Naoki;
Sugiyama, Eiji;
Yamaoka, Kunihiro;
Combe, Bernard G.;
Kivitz, Alan J.;
Sang-Cheol Bae;
Keystone, Edward C.;
Nash, Peter;
Genovese, Mark;
Matzkies, Franziska;
Bartok, Beatrix;
Pechonkina, Alena;
Akira Kondo;
Lei Ye;
Qi Gong;
Tasset, Chantal

Publication type:

Article

Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).

Published in:

Modern Rheumatology, 2022, v. 32, n. 2, p. 263, doi. 10.1093/mr/roab030

By:

Yoshiya Tanaka;
Tsukasa Matsubara;
Tatsuya Atsumi;
Koichi Amano;
Naoki Ishiguro;
Eiji Sugiyama;
Kunihiro YamaokaAUS-Department of Rheumatology and Infectious Diseases,Kitasato University School of Medicine, Kanagawa, Japan;
Combe, Bernard G.;
Kivitz, Alan J.;
Sang-Cheol Bae;
Keystone, Edward C.;
Nash, Peter;
Matzkies, Franziska;
Bartok, Beatrix;
Pechonkina, Alena;
Akira Kondo;
Lei Ye;
Ying Guo;
Tasset, Chantal;
Sundy, John S.

Publication type:

Article

The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial.

Published in:

Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1824, doi. 10.1002/art.41012

By:

Dakin, Paula;
DiMartino, Stephen J.;
Gao, Haitao;
Maloney, Jennifer;
Kivitz, Alan J.;
Schnitzer, Thomas J.;
Stahl, Neil;
Yancopoulos, George D.;
Geba, Gregory P.

Publication type:

Article

Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 12, p. 2283, doi. 10.1002/art.40319

By:

Fleischmann, Roy M.;
Wagner, Frank;
Kivitz, Alan J.;
Mansikka, Heikki T.;
Khan, Nasser;
Othman, Ahmed A.;
Khatri, Amit;
Hong, Feng;
Jiang, Ping;
Ruzek, Melanie;
Padley, Robert J.

Publication type:

Article

Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 932, doi. 10.1002/art.40054

By:

Genovese, Mark C.;
Greenwald, Maria;
Codding, Christine;
Zubrzycka‐Sienkiewicz, Anna;
Kivitz, Alan J.;
Wang, Annie;
Shay, Kathyjo;
Wang, Xuegong;
Garg, Jay P.;
Cardiel, Mario H.

Publication type:

Article

Blockade of Interferon-γ Normalizes Interferon-Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus.

Published in:

Arthritis & Rheumatology, 2015, v. 67, n. 10, p. 2713, doi. 10.1002/art.39248

By:

Welcher, Andrew A.;
Boedigheimer, Michael;
Kivitz, Alan J.;
Amoura, Zahir;
Buyon, Jill;
Rudinskaya, Alla;
Latinis, Kevin;
Chiu, Kit;
Oliner, Kelly S.;
Damore, Michael A.;
Arnold, Gregory E.;
Sohn, Winnie;
Chirmule, Narendra;
Goyal, Lovely;
Banfield, Christopher;
Chung, James B.

Publication type:

Article

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.

Published in:

Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1424, doi. 10.1002/art.39093

By:

Genovese, Mark C.;
Fleischmann, Roy;
Kivitz, Alan J.;
Rell‐Bakalarska, Maria;
Martincova, Renata;
Fiore, Stefano;
Rohane, Patricia;
van Hoogstraten, Hubert;
Garg, Anju;
Fan, Chunpeng;
van Adelsberg, Janet;
Weinstein, Steven P.;
Graham, Neil M. H.;
Stahl, Neil;
Yancopoulos, George D.;
Huizinga, Tom W. J.;
van der Heijde, Désirée

Publication type:

Article

A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2015, v. 67, n. 2, p. 334, doi. 10.1002/art.38949

By:

Fleischmann, Roy M.;
Damjanov, Nemanja S.;
Kivitz, Alan J.;
Legedza, Anna;
Hoock, Thomas;
Kinnman, Nils

Publication type:

Article

A169: Cumulative Long-Term Safety, Efficacy and Patient-Reported Outcomes in Children With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept: Up to 7 Years of Treatment.

Published in:

Arthritis & Rheumatology, 2014, v. 66, p. S218, doi. 10.1002/art.38595

By:

Lovell, Daniel J.;
Ruperto, Nicolino;
Mouy, Richard;
Paz, Eliana;
Rubio-Perez, Nadina;
Silva, Clovis A.;
Abud-Mendoza, Carlos;
Burgos-Vargas, Ruben;
Gerloni, Valeria;
Melo-Gomes, Jose A.;
Magalhaes, Claudia Saad;
Chavez-Corrales, Jose;
Huemer, Christian;
Kivitz, Alan J.;
Blanco, Francisco J.;
Foeldvari, Ivan;
Hofer, Michael;
Huppertz, Hans-Iko;
Deslandre, Chantal;
Minden, Kirsten

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 408, doi. 10.1002/cpdd.251

By:

Zhu, Tong;
Keirns, James;
Howieson, Corrie;
Kaibara, Atsunori;
Goldwater, Ronald;
Kivitz, Alan J.;
Chindalore, Vishala;
Cohen, Stanley;
Santos, Vicki;
Akinlade, Bolanle;
Kernstock, Robert;
Delgado‐Herrera, Leticia;
Blahunka, Paul C;
Karrer, Erik E.;
Garg, Jay P.;
Samberg, Nancy;
Zeiher, Bernhardt G.

Publication type:

Article

A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 259, doi. 10.1002/cpdd.237

By:

Zhang, Wenhui;
Kernstock, Robert M.;
Karrer, Erik E.;
Cohen, Stanley B.;
Chindalore, Vishala L.;
Kivitz, Alan J.;
Blahunka, Paul C.;
Delgado‐Herrera, Leticia;
Zeiher, Bernhardt G.;
Samberg, Nancy L.;
Garg, Jay P.

Publication type:

Article

A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.

Published in:

Rheumatology, 2007, v. 46, n. 7, p. 1122, doi. 10.1093/rheumatology/kem033

By:

Weisman, Michael H.;
Paulus, Harold E.;
Burch, Francis X.;
Kivitz, Alan J.;
Fierer, Joshua;
Dunn, Meleana;
Kerr, David R.;
Tsuji, Wayne;
Baumgartner, Scott W.

Publication type:

Article

A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.

Published in:

Rheumatology, 2007, v. 46, n. 7, p. 1122, doi. 10.1093/rheumatology/kem033

By:

Michael H. Weisman;
Harold E. Paulus;
Francis X. Burch;
Alan J. Kivitz;
Joshua Fierer;
Meleana Dunn;
David R. Kerr;
Wayne Tsuji;
Scott W. Baumgartner

Publication type:

Article

Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial.

Published in:

Journal of the American Geriatrics Society, 2004, v. 52, n. 5, p. 666, doi. 10.1111/j.1532-5415.2004.52201.x

By:

Kivitz, Alan J.;
Greenwald, Maria W.;
Cohen, Stanley B.;
Polis, Adam B.;
Najarian, Daryl K.;
Dixon, Mary E.;
Moidel, Robert A.;
Green, Jerry A.;
Baraf, Herbert S. B.;
Petruschke, Richard A.;
Matsumoto, Alan K.;
Geba, Gregory P.

Publication type:

Article

Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials.

Published in:

Pain & Therapy, 2019, v. 8, n. 2, p. 271, doi. 10.1007/s40122-019-0125-1

By:

Kivitz, Alan J.;
Conaghan, Philip G.;
Cinar, Amy;
Lufkin, Joelle;
Kelley, Scott D.

Publication type:

Article

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 2, p. 168, doi. 10.1002/jcph.239

By:

Padhi, Desmond;
Allison, Mark;
Kivitz, Alan J.;
Gutierrez, Maria J.;
Stouch, Brian;
Wang, Christine;
Jang, Graham

Publication type:

Article

Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study.

Published in:

Arthritis & Rheumatology, 2022, v. 74, n. 12, p. 1943, doi. 10.1002/art.42282

By:

Baraliakos, Xenofon;
Deodhar, Atul;
Dougados, Maxime;
Gensler, Lianne S.;
Molto, Anna;
Ramiro, Sofia;
Kivitz, Alan J.;
Poddubnyy, Denis;
Oortgiesen, Marga;
Vaux, Thomas;
Fleurinck, Carmen;
Shepherd‐Smith, Julie;
de la Loge, Christine;
de Peyrecave, Natasha;
van der Heijde, Désirée

Publication type:

Article

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study.

Published in:

Arthritis & Rheumatology, 2021, v. 73, n. 1, p. 110, doi. 10.1002/art.41477

By:

Deodhar, Atul;
Blanco, Ricardo;
Dokoupilová, Eva;
Hall, Stephen;
Kameda, Hideto;
Kivitz, Alan J.;
Poddubnyy, Denis;
Sande, Marleen;
Wiksten, Anna S.;
Porter, Brian O.;
Richards, Hanno B.;
Haemmerle, Sibylle;
Braun, Jürgen

Publication type:

Article

Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.

Published in:

2016

By:

Kavanaugh, Arthur;
Mclnnes, Iain B.;
Mease, Philip J.;
Hall, Stephen;
Chinoy, Hector;
Kivitz, Alan J.;
Zailong Wang;
Mpofu, Shephard;
McInnes, Iain B;
Wang, Zailong

Publication type:

journal article

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54–78 Data From a Randomized, Double-Blind, Phase III Trial

Published in:

BioDrugs, 2020, v. 34, n. 2, p. 197, doi. 10.1007/s40259-019-00403-z

By:

Cohen, Stanley B.;
Radominski, Sebastiao C.;
Kameda, Hideto;
Kivitz, Alan J.;
Tee, Michael;
Cronenberger, Carol;
Zhang, Min;
Hackley, Sarah;
Rehman, Muhammad I.;
von Richter, Oliver;
Alten, Rieke

Publication type:

Article

General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials.

Published in:

Arthritis Care & Research, 2022, v. 74, n. 6, p. 918, doi. 10.1002/acr.24637

By:

Berenbaum, Francis;
Schnitzer, Thomas J.;
Kivitz, Alan J.;
Viktrup, Lars;
Hickman, Anne;
Pixton, Glenn;
Brown, Mark T.;
Davignon, Isabelle;
West, Christine R.

Publication type:

Article

Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis.

Published in:

2019

By:

Tony, Hans‐Peter;
Krüger, Klaus;
Cohen, Stanley B.;
Schulze‐Koops, Hendrik;
Kivitz, Alan J.;
Jeka, Sławomir;
Vereckei, Edit;
Cen, Liyi;
Kring, Laura;
Kollins, Dmitrij;
Tony, Hans-Peter;
Schulze-Koops, Hendrik

Publication type:

journal article

Twice Daily Versus Once Nightly Dosing of Pregabalin for Fibromyalgia: A Double-Blind Randomized Clinical Trial of Efficacy and Safety.

Published in:

Arthritis Care & Research, 2014, v. 66, n. 2, p. 293, doi. 10.1002/acr.22111

By:

Nasser, Keaton;
Kivitz, Alan J.;
Maricic, Michael J.;
Silver, David S.;
Silverman, Stuart L.

Publication type:

Article

Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study.

Published in:

Arthritis Care & Research, 2013, v. 65, n. 5, p. 718, doi. 10.1002/acr.21876

By:

Nash, Peter;
Nayiager, Sauithree;
Genovese, Mark C.;
Kivitz, Alan J.;
Oelke, Kurt;
Ludivico, Charles;
Palmer, William;
Rodriguez, Cristian;
Delaet, Ingrid;
Elegbe, Ayanbola;
Corbo, Michael

Publication type:

Article

Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making.

Published in:

Patient Preference & Adherence, 2020, v. 14, p. 119, doi. 10.2147/PPA.S220714

By:

Taylor, Peter C;
Betteridge, Neil;
Brown, T Michelle;
Woolcott, John;
Kivitz, Alan J;
Zerbini, Cristiano;
Whalley, Diane;
Olayinka-Amao, Oyebimpe;
Chen, Connie;
Dahl, Palle;
Leon, Dario Ponce de;
Gruben, David;
Fallon, Lara

Publication type:

Article

Simulating clinical trial visits yields patient insights into study design and recruitment.

Published in:

Patient Preference & Adherence, 2017, v. 11, p. 1295, doi. 10.2147/PPA.S137416

By:

Lim, S. Sam;
Kivitz, Alan J.;
McKinnell, Doug;
Pierson, M. Edward;
O'Brien, Faye S.

Publication type:

Article

Corrigendum: Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers.

Published in:

2012

By:

Laine, Loren;
Kivitz, Alan J;
Bello, Alfonso E;
Grahn, Amy Y;
Schiff, Michael H;
Taha, Ali S

Publication type:

Erratum

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers.

Published in:

American Journal of Gastroenterology (Springer Nature), 2012, v. 107, n. 3, p. 379, doi. 10.1038/ajg.2011.443

By:

Laine, Loren;
Kivitz, Alan J;
Bello, Alfonso E;
Grahn, Amy Y;
Schiff, Michael H;
Taha, Ali S

Publication type:

Article

Assessing usability, label comprehension, pen robustness and pharmacokinetics of a selfadministered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis.

Published in:

SAGE Open Medicine, 2014, v. 2, p. 1, doi. 10.1177/2050312114564241

By:

Pachon, Jaime A.;
Kivitz, Alan J.;
Heuer, Kay-Uwe;
Pichlmeier, Uwe

Publication type:

Article

Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials.

Published in:

Clinical Rheumatology, 2022, v. 41, n. 2, p. 499, doi. 10.1007/s10067-021-05894-2

By:

Kivitz, Alan J.;
FitzGerald, Oliver;
Nash, Peter;
Pang, Shirley;
Azevedo, Valderilio F.;
Wang, Cunshan;
Takiya, Liza

Publication type:

Article

Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study

Published in:

ACR Open Rheumatology, 2022, v. 4, n. 10, p. 903, doi. 10.1002/acr2.11487

By:

Abuqayyas, Lubna;
Cheng, Laurence E.;
Teixeira dos Santos, Marcia;
Sullivan, Barbara A.;
Ruiz‐Santiago, Norma;
Wang, Hui;
Zhou, Yanchen;
Chindalore, Vishala;
Cohen, Stanley;
Kivitz, Alan J.;
Posch, Maximilian G.;
Parnes, Jane R.

Publication type:

Article

Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3‐Year Results from the Phase 3 MEASURE 3 Study.

Published in:

ACR Open Rheumatology, 2020, v. 2, n. 2, p. 119, doi. 10.1002/acr2.11102

By:

Pavelka, Karel;
Kivitz, Alan J.;
Dokoupilova, Eva;
Blanco, Ricardo;
Maradiaga, Marco;
Tahir, Hasan;
Wang, Yi;
Porter, Brian O.;
Stefanska, Anna;
Richards, Hanno B.;
Rohrer, Susanne

Publication type:

Article

Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial.

Published in:

Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0612-7

By:

Kremer, Joel M.;
Kivitz, Alan J.;
Simon-Campos, Jesus A.;
Nasonov, Evgeny L.;
Tony, Hans-Peter;
Soo-Kon Lee;
Vlahos, Bonnie;
Hammond, Constance;
Bukowski, Jack;
Huihua Li;
Schulman, Seth L.;
Raber, Susan;
Zuckerman, Andrea;
Isaacs, John D.

Publication type:

Article

Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial

Published in:

Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 95, doi. 10.1186/s13075-015-0612-7

By:

Kremer, Joel M;
Kivitz, Alan J;
Simon-Campos, Jesus A;
Nasonov, Evgeny L;
Tony, Hans-Peter;
Soo-Kon Lee;
Vlahos, Bonnie;
Hammond, Constance;
Bukowski, Jack;
Li, Huihua;
Schulman, Seth L;
Raber, Susan;
Zuckerman, Andrea;
Isaacs, John D

Publication type:

Article

A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee.

Published in:

Arthritis Research & Therapy, 2011, v. 13, n. 4, p. 1, doi. 10.1186/ar3430

By:

Cohen, Stanley B.;
Proudman, Susanna;
Kivitz, Alan J.;
Burch, Francis X.;
Donohue, John P.;
Burstein, Deborah;
Yu-Nien Sun;
Banfield, Christopher;
Vincent, Michael S.;
Liyun Ni;
Zack, Debra J.

Publication type:

Article

Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis.

Published in:

Expert Review of Molecular Diagnostics, 2022, v. 22, n. 1, p. 101, doi. 10.1080/14737159.2022.2020648

By:

Strand, Vibeke;
Cohen, Stanley B.;
Curtis, Jeffrey R.;
Zhang, Lixia;
Kivitz, Alan J.;
Levin, Robert W.;
Mathis, Angela;
Connolly-Strong, Erin;
Withers, Johanna B.

Publication type:

Article

A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment.

Published in:

Rheumatology, 2025, v. 64, n. 4, p. 1864, doi. 10.1093/rheumatology/keae432

By:

Deodhar, Atul;
Kivitz, Alan J;
Magrey, Marina;
Walsh, Jessica A;
Mease, Philip J;
Greenwald, Maria;
Kianifard, Farid;
Elam, Chelsea;
Bommidi, Gopi M;
Winseck, Adam;
Gensler, Lianne S

Publication type:

Article